Prototyping of a lateral flow assay based on monoclonal antibodies for detection of Bothrops venoms

Anal Chim Acta. 2023 Sep 1:1272:341306. doi: 10.1016/j.aca.2023.341306. Epub 2023 May 1.

Abstract

Background: Brazil is home to a multitude of venomous snakes; perhaps the most medically relevant of which belong to the Bothrops genus. Bothrops spp. are responsible for roughly 70% of all snakebites in Brazil, and envenomings caused by their bites can be treated with three types of antivenom: bothropic antivenom, bothro-lachetic antivenom, and bothro-crotalic antivenom. The choice to administer antivenom depends on the severity of the envenoming, while the choice of antivenom depends on availability and on how certain the treating physician is that the patient was bitten by a bothropic snake. The diagnosis of a bothropic envenoming can be made based on expert identification of the dead snake or a photo thereof or based on a syndromic approach wherein the clinician examines the patient for characteristic manifestations of envenoming. This approach can be very effective but requires staff that has been trained in clinical snakebite management, which, unfortunately, far from all relevant staff has.

Results: In this article, we describe a prototype of the first lateral flow assay (LFA) capable of detecting venoms from Brazilian Bothrops spp. The monoclonal antibodies for the assay were generated using hybridoma technology and screened in sandwich enzyme-linked immunosorbent assays (ELISAs) to identify Bothrops spp.-specific antibody sandwich pairs. The prototype LFA is able to detect venom from several Bothrops spp. The LFA has a limit of detection (LoD) of 9.5 ng/mL in urine, when read with a commercial reader, and a visual LoD of approximately 25 ng/mL.

Significance: The work presented here serves as a proof of concept for a genus-specific venom detection kit that could support physicians in diagnosing Bothrops envenomings. Although further optimisation and testing is needed before the LFA can find clinical use, such a device could aid in decentralising antivenoms in the Brazilian Amazon and help ensure optimal snakebite management for even more victims of this highly neglected disease.

Keywords: Diagnostics; Lateral flow assay; Neglected tropical diseases; Point-of-care; Prototype; Snakebite envenoming.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antivenins / therapeutic use
  • Bothrops*
  • Crotalid Venoms* / therapeutic use
  • Snake Bites* / diagnosis
  • Snake Bites* / drug therapy

Substances

  • Antivenins
  • Crotalid Venoms
  • Antibodies, Monoclonal